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ABSTRACT
Xerostomia is a particularly frequent occurrence among menopausal women, and is often associated with depression.
Objectives: To evaluate the relationship between unstimulated salivary flow rate and the presence of xerostomia, and to 
determine the levels of salivary cortisol and its relationship with xerostomia.
Study design: Thirty women were selected from patients attending the Department of Medicine and Buccofacial surgery, 
and formed into two groups, study and control. Samples of unstimulated salivary flow were collected, and the amounts 
of salivary cortisol determined using the ELISA technique (enzyme-linked immunosorbent assay).
Results: The mean unstimulated salivary flow rates for the control and study group were 0.37 ± 0.28 ml/min and 0.24 ± 
0.18 ml/min, respectively. The concentration of salivary cortisol was 3.47 ± 1.64 ng/ml for the control group and 2.29 ± 
2.60 ng/ml for the study group. The statistical tests applied showed no significant differences for either variable between 
the two groups in the study.
Conclusions: The results of the present study indicate that there is no relationship between variations in the rates of 
unstimulated salivary flow and the corresponding concentration of cortisol.
Key words: Xerostomia, hyposalivation, unstimulated salivary flow, cortisol, depression, menopause.
RESUMEN
La xerostomía es un síntoma especialmente frecuente en las mujeres en torno a la menopausia, que se asocia en muchas 
ocasiones con estados depresivos.
Objetivos: Valorar la relación entre las cifras del flujo salival total no estimulado y la presencia de xerostomía, y deter-
minar los niveles de cortisol salival y su relación con la misma.
Diseño del estudio: Se seleccionaron 30 mujeres de los pacientes que acuden al Departamento de Medicina y Cirugía 
Bucofacial y se formaron dos grupos, estudio y control. Se recogieron muestras de flujo salival total no estimulado y 
mediante técnica de ELISA se determinaron las cifras de cortisol salival.
Resultados: Las medias de flujo salival total no estimulado para el grupo control y estudio fueron de 0.37± 0.28 ml/min. 
y de 0.24± 0.18 ml/min. respectivamente. La concentración de cortisol salival fue de 3.47± 1.64 ng/ml. para el grupo 
control y de 2.29± 2.60 ng/ml. para el grupo estudio. Las pruebas estadísticas aplicadas no mostraron diferencias signi-
ficativas entre los dos grupos del estudio para ambas variables.
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INTRODUCTION
Dry mouth is a relatively common symptom. When we 
examine the literature, we see  a wide variation in the data, 
which offers figures for prevalence of between 14 and 46%, 
being consistently higher among women (1-3). Dry mouth 
is found to be more common within the older population, 
where its frequency oscillates between 13 and 39% for those 
able to look after themselves, and increasing up to 60% in 
institutionalized or hospitalized individuals (3,4). Changes 
in the salivary glands are related to age; however there is 
no evidence that xerostomia is solely a result of the aging 
process (5). Of  the different causes observed (6), those 
more frequently associated with xerostomia are menopause 
(7,8) and certain depressive conditions (9,10). Menopause 
is defined as the permanent (after 12 months) cessation of 
menstruation resulting from the loss of ovarian function. 
The age at which physiological menopause appears is bet-
ween 45 and 55 years, with an average of 52.5 years (11). 
Many menopausal women suffer changes in mood (12), 
especially depressive disorders, which have been associated 
with xerostomia (9, 10, 13), although the causal relationship 
between these two factors and dry mouth is unclear.
With regard to depression and its relationship with the ap-
pearance of xerostomia, various studies have used different 
tests to evaluate the psychological condition, establishing 
a direct relationship between these variables, both with the 
appearance of the symptomatology and with its disappea-
rance on the improvement of the depression (9,10).
Studies that evaluate the levels of cortisol in patients su-
ffering from depression have shown variable results, with 
notable differences between these studies. While some au-
thors indicate that a deficit in cortisol is related with chronic 
episodes of depression, others note that elevated levels of 
endogenous glucocorticoids may cause psychiatric disor-
ders such as depression (14-16). These latter authors also 
indicate that older patients, a condition particularly related 
to xerostomia (17), and children are more vulnerable to the 
effects of high levels of glucocorticoids on brain function. 
In general terms, differences in salivary cortisol seem to exist 
between depressed patients and healthy individuals (15,18). 
For this reason, cortisol levels could be used as a biological 
marker for changes related to anxiety and depression, and 
although its predictive value is controversial, this possible 
relationship would be a relevant finding for the multidisci-
plinary management of these patients.
Based on the above, and due to the high prevalence of xe-
rostomia in menopausal women with mood disorders, the 
purpose of this study was to evaluate if  those patients with 
a subjective sensation of dry mouth presented modifications 
in salivary cortisol. In addition, and given the relationship 
between this hormone and depressive states, to compare 
these patients with those who did not refer such a sensation. 
Therefore, the objectives we stated were: to evaluate the rela-
tionship between the rates of unstimulated salivary flow and 
the presence of xerostomia in menopausal women, and to 
determine the levels of salivary cortisol and its relationship 
with the sensation of a dry mouth.
MATERIAL AND METHOD
Thirty patients, with informed consent, were selected by 
non-probable sample from those attending our department. 
Two groups were formed, study and control, with 15 patients 
in each group. Selection criteria for the study group were: 
female, aged 45 or older, cessation of menstruation for at 
least 12 months, hormonal analysis compatible with meno-
pause and a diagnosis of xerostomia (Table 1). The control 
group was constituted by patients meeting the same criteria 
with the exception of a diagnosis of xerostomia.
Exclusion criteria included all clinical symptoms of xeros-
tomia produced by specific causes. Likewise, patients under 
treatment for xerostomia were also excluded; as were those 
taking natural or synthetic corticosteroids for prolonged 
periods due to the suppression of the hypothalamus-hypo-
physis-adrenal system produced (Table 2).
The salivary flow was measured for all patients included in 
the study. To obtain the samples of unstimulated salivary 
flow, specifically designed collection tubes graduated in 
millimeters were used, and labeled according to a system 
of letters and numbers, the letter indicated the group to 
which the patient belonged and the number indicating the 
order in which the samples were taken. Prior to taking the 
sample, the patient had a mouthwash of water in order to 
eliminate any possible detritus and so obtain a clean sample. 
The patient was then instructed to deposit at intervals all 
the saliva accumulated over a period of 5 minutes into the 
tube. Once the sample had been obtained it was allowed to 
settle, placing the tube in a test tube rack, in order to achieve 
a better reading of the saliva volume.
After taking the reading, the samples were sent to the 
laboratory where they were stored until the cortisol was 
determined. This was carried out using the ELISA techni-
que (enzyme linked immunoabsorbent assay), the principal 
of which is based on the competition between the cortisol 
(antigen) and an enzyme-labeled antigen to bind with an 
antibody situated on the microplates.  To carry out this assay, 
the specifically developed DiaMetra® kit for the detection 
of cortisol in saliva was used.
The statistical analysis was carried out on the data obtained 
using the SPSS 11.0 statistical package. For the comparison 
of both mean variables for each group the student’s t test 
Conclusiones: Los resultados del presente estudio indican que no existe relación entre las variaciones en el flujo salival 
total no estimulado y las concentraciones de cortisol correspondientes.
Palabras clave: Xerostomía, hiposialia, flujo salival total no estimulado, cortisol, depresión, menopausia. 
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was used. Due to the impossibility of eliminating from the 
study all those patients taking potentially xerostomizing 
medication, since this would create an insufficient sample 
size, a Pearson’s correlation coefficient and a multivariate 
analysis were made in order to analyze the above mentioned 
confusion factor. To this end the two groups were subdivided 
into 5 subgroups according to the particular medication being 
taken by each patient, numbered from 1 to 5 as follows: group 
1 – anxiolytics, sedatives and hypnotics; group 2 – antihy-
pertensives; group 3 – analgesics; group 4 – antidepressants; 
group 5 – others (bronchodilators, antihistamines).
RESULTS
The concentration of unstimulated salivary flow (mean and 
standard deviation) of all the samples was 0.30±0.24 ml/
min. The salivary flow rates for the study and control groups 
(mean and standard deviation) were 0.24±0.18 ml/min and 
0.37±0.28 ml/min respectively. However, although the con-
trol group presented higher figures than the study group, 
these results were not statistically significant (p=0.18). This 
difference can be seen in Figure 1a, which shows the distri-
bution of the position values for both groups.
The total concentration of salivary cortisol (mean and stan-
dard deviation) was 2.89±2.17 ng/ml. The total concentra-
tion of salivary cortisol for the study and the control groups 
was 2.29±2.60 ng/ml and 3.47±1.64 ng/ml respectively. This 
difference, as for the salivary flow, was not statistically 
significant (p=0.16). Figure 1b shows the distribution of 
the position values for the total concentration of salivary 
cortisol for the two groups in the study where this difference 
can be observed.
The study group presented lower salivary flow rates than 
the control group, although the control group presented 
higher levels of concentration of cortisol (fig 2a and 2b). 
With regard to the mean salivary flow corresponding to the 
different pharmacological groups, neither the study nor the 
control groups showed statistically significant differences 
between them (p>0.05) (fig.3). The multivariate analysis 
for the different groups offered values of p>0.05, that is 
to say, there were no statistically significant differences in 
the modifications of unstimulated salivary flow between 
the study and control groups in relation to the medications 
being taken.
Female. 
Aged 45 or over. 
Cessation of menstruation for 12 months. 
Hormonal analysis compatible with menopause. 
Local inflammation. 





Post radiotherapy changes. 
Chemotherapy. 
Alcoholism. 
Treatment for xerostomia. 
Prolonged corticotherapy. 
Table 1. Inclusion criteria.





















Fig. 1a. Unstimulated salivary flow by group (ml/min). 
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DISCUSSION
According to the International Dental Federation (IDF), 
50% of the over 40-50-year-old population present an ob-
jective decrease in salivary flow, or hyposalivation, a figure 
which increases up to 70% when referring to the population 
over 70 years of age (19).
The mean unstimulated salivary flow rates for the study and 
control group in our study were 0.24 ml/min and 0.37 ml/min 
respectively, figures which can be considered as normal for a 
population of this age (1); however, there were no statistically 
significant differences between the groups. Therefore, and in 
agreement with other authors, we can say that the decrease 
in the rate of salivary flow is not an essential condition for 
the development of the sensation of a dry mouth (17). In this 
respect, Thomson et al. in a study carried out on a population 
of 939 people, found that the prevalence of xerostomia and 
hyposalivation were 20.5 and 22.1% respectively; and that 
only 5.7% of the total population in that study presented both 
characteristics. The distribution by sex showed that 8.1% of 
the women had both conditions, while only 3.1% of the men 
referred xerostomia and also presented a decrease in salivary 
flow (4). Likewise, Pajukoski et al. affirmed that the subjec-
tive sensation of a dry mouth, xerostomia, is not necessarily 
associated with hyposalivation (20). This association between 
xerostomia and hyposalivation is not a constant. Xerostomia 
can occur in spite of the existence of correct glandular func-
tion and normal salivary flow rates, as appears in our study 
and confirmed in the studies of Ship et al., who observed that 
healthy postmenopausal women, the principal risk group (6), 
did not present a deterioration in glandular function nor a 
reduction in salivary flow. On the other hand, Närhi et al. 
(17), as other authors (21), affirmed that a decrease in salivary 
flow rate does exist following menopause (8, 17), however, 
they did not find statistically significant differences in the 
unstimulated salivary flow rates between subjects with dry 
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Fig. 2a. Comparison of the mean salivary flow of the study and control 
groups. The higher mean obtained for the control group over the study 
group can be seen.
Fig. 2b. Comparison of the mean salivary cortisol for the study and 
control groups. The higher levels found in the control group over the 
study group can be observed.
Fig. 3. Comparison of total salivary flow by pharmacological group. The 
differences in salivary flow for all groups depending on the medications 
considered can be seen, being the control group which presented a higher 
mean than the study group for all pharmacological groups.
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Pharmaceutical treatment plays an important role in the 
reduction of the unstimulated salivary flow (1,22). With 
respect to the most common medications, it would seem 
that the antihypertensives are those that generate the highest 
hyposalivation (22), although drugs such as tranquilizers, se-
datives, antipsychotics, hypnotics and some antidepressants 
are also associated with a reduction in stimulated salivary 
flow (1). In our study, the results demonstrate that there is no 
correlation between the different groups of drugs classically 
considered as causing xerostomia, and modifications in the 
salivary flow rates. Likewise, on analyzing the relationship 
between these subgroups no statistically significant differen-
ces appear among them (p>0.05). This important finding 
should be interpreted with caution, given the small sample 
size (n=30), it would therefore be interesting to carry out 
a similar study on a larger population in order to increase 
the external validity of the results.
This data would seem to suggest that the taking of me-
dication does not have a constant effect in relation to the 
development of  hyposalivation, which could be due to 
certain individual characteristics of susceptibility (23,24). 
This would explain, to a certain extent, why of all individuals 
taking a certain medication, only some refer xerostomia. The 
same occurs with hyposalivation, since not all the subjects 
taking potentially xerostomizing medication present an 
objective reduction in the salivary flow.
The sensation of a dry mouth is related to the presence 
of increased levels of anxiety and/or certain alterations in 
mood, such as depression (9,10). Depression is a disorder in 
which a series of etiopathogenic elements: genetic, somatic, 
psychic and sociocultural factors, among others, can affect a 
predisposed personality (25). A theory which combines these 
factors is the so-called stress-diathesis model, according to 
which some people inherit a susceptibility to develop depres-
sion, possibly due to the fact that their monoaminergic syste-
ms are hypoactive, their hypothalamus-hypophysis- adrenal 
cortex systems are hyperactive or to a combination of both 
(26). Cortisol, a glucocorticoid synthesized by the adrenal 
cortex, plays a vital role in stressful situations by blocking 
the production and liberation of multiple hormones and 
neurotransmitters, which, in the absence of such control can 
lead to a state of shock. Furthermore, glucocorticoids are 
known to have a complex effect on the brain (25).
Since the beginning of the 20th century, it has been recog-
nized that saliva is a biological fluid that constitutes a non-
invasive method for detecting a wide range of hormones, 
drugs and antibodies (27,28). Of all the determinations that 
can be performed in saliva, that of cortisol is able to exactly 
and efficiently quantify the biologically active cortisol, and 
therefore constitutes an adequate method for evaluating the 
response to stress in humans (29). Moreover, the amount of 
salivary cortisol adequately represents the plasmatic figures 
(14), which, when linked to the minimal invasiveness of 
this technique could favor its substitution of the plasmatic 
technique in the future.
In agreement with the above, Hill and Walker (18), found in 
increased amount of salivary cortisol in those patients with 
higher levels of anxiety, measured on the HAD (Hospital 
Anxiety Depression) scale. In addition, Galard et al. (14,15) 
also found an increase in the levels of salivary cortisol in 
patients with depression.
The mean concentrations of salivary cortisol for the control 
and the study group obtained in this study were 3.47 and 
2.29 ng/ml respectively. Although the amounts of cortisol 
were higher in the control group than in the study group, 
the differences were not statistically significant.
In the literature, the relationship between the levels of sa-
livary cortisol and the presence of certain mood disorders 
such as depression (32), and stress are amply documented 
(33); however, within the field of oral medicine references 
are scarce. Specifically, there are only two studies which eva-
luate the amounts of salivary cortisol in patients with lichen 
planus (34,35) and one in patients with recurrent aphthous 
stomatitis (36), entities which have both been related with 
stress. While some authors (34,36) find an association bet-
ween these pathologies and variations in the levels of saliva-
ry cortisol, others (35) on the contrary affirm that no such 
relationship exists. With respect to the association between 
the variations in levels of salivary cortisol in patients with 
xerostomia, Johnson et al. (37), found low levels in patients 
with xerostomia who suffered from Sjögren’s syndrome in 
comparison with healthy controls. In our study, perhaps 
the fact that we excluded patients with Sjögren’s syndrome 
from the study group may be the reason for the discrepancy 
between our data and those of other authors. Furthermore, 
another factor to be taken into consideration is the sample 
size, which may be insufficient to determine significant 
differences between the groups.
The results of the present study do not demonstrate the 
existence of a statistically significant relationship between 
the variations in unstimulated salivary flow and the corres-
ponding concentrations of salivary cortisol. Likewise, there 
is no correlation between the taking of medications and a 
reduction in salivary flow, and therefore other possible etio-
logic agents should be investigated. The frequent appearance 
of certain mood disorders (depression) in conjunction with 
xerostomia, is such that we believe it would be interesting 
to carry out further studies on a larger series of patients 
and to also evaluate this last variable (depression), through 
specifically designed psychological tests, with the aim of 
clarifying its role in the development of xerostomia.
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